Emerging Biotech Academy

February 15, 2018

Emerging biotech companies should have access to the knowledge and experience necessary for a successful journey from discovery to the clinic. Therefore, we are starting Emerging Biotech Academy, where biotech and pharmaceutical companies in preclinical phase and phase I can easily attend courses of their interest.

The aim is to have Emerging Biotech Academy up and running by the summer of 2018. We need to understand your needs to define the course offering, including both technical and practical training elements.
Please help us by filling out this short questionnaire and perhaps we can help you out later this year.

Emerging Biotech Academy is a collaboration of Biotech Training Facility and Merck.

“Merck is a trademark of Merck KGaA, Darmstadt, Germany or its affiliates.  All other trademarks are the property of their respective owners. Detailed information on trademarks is available via publicly accessible resources”